Antiproteinuric effect of ciclosporin a in adriamycin nephropathy in rats

Nephron

Volumn 75, Issue 3, 1997, Pages 336-341

  Desassis, J F ^a   Raats, C J I ^a   Bakker, M A H ^a   Van den Born, J ^a   Berden, J H M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adriamycin nephropathy; Albuminuria; Antiproteinuric effect; Ciclosporin

Indexed keywords

ALBUMIN; CYCLOSPORIN A; DOXORUBICIN; LYSINE;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLOMERULUS CAPILLARY; GLOMERULUS FILTRATION RATE; IMMUNOLOGY; KIDNEY DISEASE; MALE; MEMBRANE PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT;

EID: 0031053195     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189558     Document Type: Article

References (33)

1. Meyrier A: Antiproteinuric and immunological effects of cyclosporine A in the treatment of glomerular diseases. Nephrol Dial Transplant 1992:7(suppl l):80-84.
2. Meyrier A: Use of cyclosporin in the treatment of idiopathic nephrotic syndrome in adults: in Tejani A (cd): Cyclosporin in the Therapy of Renal Disease. Contrib Nephrol. Basel, Karger. 1995. vol 114, pp 28-48.
3. Zietse R. Wenting GJ. Kramer P. Mulder P. Schalekamp MA. Weimar W: Contrasting response to cyclosporin in refractory nephrotic syndrome. Clin Nephrol 1989;31:22-25.
4. Schrijver G, Wetzels JFM. Robben JCM. Ass-mann KJM, Kocnc RAP. Berden JHM: Antiproteinuric effect of cyclosporine A in passive antiglomerular basement membrane nephritis in the mouse. Transplant Proc 1989;20(suppl 3):304-308.
5. Schrijver G, Assmann KJM. Wetzels JFM, Berden JHM: Ciclosporin A reduces albuminuria in experimental anti-GBM nephritis independently from changes in GFR. Nephrol Dial Transplant 1995;10:1149-1154.
6. Zietse R. Wenting GJ. Kramer P. Schalekamp MADH, Weimar W: Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome. Clin Sci 1992:82:641-650.
7. Jameson MD. Savin VJ. Sharma R. Lovell HB, Diederich DA: Ciclosporine treatment decreases glomerular ultrafiltration coefficient (abstract). Clin Res 1989:37:951.
8. Wiegmann TB, Sharma R. Diederich DA. Savin VJ: In vitro effects of cyclosporine on glomerular function. Am J Med Sci 1990:299: 149-152.
9. Tejani A. Butt K. Trachtman H, Suthantiran M, Rosenthal C, Khawar M: Ciclosporin A induced remission of relapsing nephrotic syndrome in children. Kidney Int 1988:33:729-734.
10. Ponticelli C. Rizzoni G. Edefonti A. Altieri P. Rivolla E, Rinaldi S. Ghio L, Lusvarghi E, Gusmano R, Locatelli F, Pasquali S, Castellani A, Della Casa-Alberighi O: A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int 1993:43: 1377-1384.
11. Melocoton TL. Kamil ES. Cohen AH. Fine RN: Long-term cyclosporine A treatment of steroid-resistant and steroid-dependent nephrotic syndrome. Am J Kidney Dis 1991:18:583-588.
12. Meyrier A, Noel LH. Aurichc P. Callard P: Long-term tolerance of cylcosporin A treatment in adult idiopathic nephrotic syndrome. Kidney Int 1994;45:1446-1456.
13. Levine M, Gascoinc P. Turner MW. Barratt TM: A highly cationic protein in plasma and urine of children with steroid-responsive nephrotic syndrome. Kidney Int 1989:36:867-877.
14. Bertani T. Poggi A. Pozzoni R. Dclaini F. Sac-chi G, Thoua Y, Mecca G. Remuzzi Ci. Donati MB: Adriamycin-induced nephrotic syndrome in rats. Lab Invest 1982:46:16-23.
15. Weening JJ. Rennke HG: Glomerular permeability and polyanion in Adriamvcin nephrosis in the rat. Kidney Int 1983;24:152-159.
16. Laurell CB: Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966:15:45-52.
17. Van den Born J. Van den Heuvel LPWJ. Bak-ker MAH. Veerkamp JH. Assmann KJM. Berden JHM: A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney Int 1992:41: 115-123.
18. Provoost AP, De Keijzer MH, Wolff HD. Mo-lenaar JC: Development of renal function in the rat. Renal Physiol 1983;6:1-9.
19. Bertolatus JA, Hunsicker LG: Glomerular sieving of anionic and neutral bovine albumins in proteinuric rats. Kidney Int 1985;28:467-476.
20. De Zceuw D. Tomasini R, Haas M. De Jong PE. Weening JJ, Van der Hem GK: Effect of mild charge modification of albumin on renal excretion in the rat: in Bianchi C. Bocci V, Carone FA, Rabkin R (eds): Kidney and Proteins in Health and Disease. Contrib Nephrol. Basel, Karger. 1988, vol 68. pp 121-127.
21. Remuzzi A, Battaglia C, Rossi L, Zoja C, Re-muzzi G: Glomerular size selectivity in nephrotic rats exposed to diets with different protein content. Am J Physiol 1987:253:F318-F327.
22. Bertolatus JA. Abuyousef M. Hunsicker LG: Glomerular sieving of high molecular weight proteins in proteinuric rats. Kidney Int 1987: 31:1257-1266.
23. Van den Bom J. Desassis JF. Berden JHM: Decrease of heparan sulphate in adriamycin nephropathy (abstract). J Am Soc Nephrol 1992;3:647.
24. Whiteside C. Prutis K. Cameron R. Thompson J: Glomerular epithelial detachment, not reduced charge density, correlates with proteinuria in Adriamycin and puromvein nephrosis. Lab Invest 1989;61:650-659.
25. Skutclsky E, Hartzan S. Sochcr R, Gafter U: Modifications in glomerular polvanion distribution in Adriamycin nephrosis. J Am Soc Nephrol 1995:5:1799-1805.
26. Benjelloun AS. Mcrville P. Cambar P. Apari-cio M: Effects of low-protein diet on urinary glycosaminoglycan excretion in Adriamycin-treated rats. Nephron 1993:64:242-248.
27. Kanwar YS. Rosenzweig LJ: Clogging of the glomerular basement membrane. J Cell Biol 1982:93:489-494.
28. Doroshow JH. Akman S. Chu F, Esworthy S: Role of the glutathione-peroxidase cycle in the toxicity of the anticancer quiñones. Pharmacol Ther 1990;47:359-370.
29. Ginevri F, Gusmano R. Oleggini R, Acerbo S. Bertelli R. Perfumo F. Ccrcignani G, Allcgrini S. D'Allcgri F, Ghiggeri G: Renal purine efflux and xanthine oxidase activity during experimental nephrosis in rats: Difference between puromycin aminonucleoside and Adriamycin nephrosis. Clin Sci (Colch) 1990:78:283-293.
30. Kerjaschki D: Epitopes and radicals: Early events in glomerular injury in membranous nephropathy. Exp Nephrol 1995:3:1-8.
31. Shah SV: Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int 1989:36:1093-1106.
32. Diamond JR: Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis. Kidney Int 1991;31(suppl):29-34.
33. Chiara MD. Bedoya F. Sobrino F: Ciclosporin A inhibits phorbol esther-induccd activation of superoxide production in resident mouse peritoneal macrophages. Biochem J 1989:264:21-26.